ArticleCancer medicine2023

Comparison of gemcitabine plus oxaliplatin versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma: A single-center retrospective analysis.

Konstantin Schlick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.